KR102493423B1 - A method of detecting target rna comprising silica treatment - Google Patents

A method of detecting target rna comprising silica treatment Download PDF

Info

Publication number
KR102493423B1
KR102493423B1 KR1020210009517A KR20210009517A KR102493423B1 KR 102493423 B1 KR102493423 B1 KR 102493423B1 KR 1020210009517 A KR1020210009517 A KR 1020210009517A KR 20210009517 A KR20210009517 A KR 20210009517A KR 102493423 B1 KR102493423 B1 KR 102493423B1
Authority
KR
South Korea
Prior art keywords
dna
rna
silica
target rna
sensor
Prior art date
Application number
KR1020210009517A
Other languages
Korean (ko)
Other versions
KR20220106525A (en
Inventor
조석근
변미영
유문영
Original Assignee
주식회사 제노헬릭스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 제노헬릭스 filed Critical 주식회사 제노헬릭스
Priority to KR1020210009517A priority Critical patent/KR102493423B1/en
Publication of KR20220106525A publication Critical patent/KR20220106525A/en
Application granted granted Critical
Publication of KR102493423B1 publication Critical patent/KR102493423B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • C12Q1/6825Nucleic acid detection involving sensors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2527/00Reactions demanding special reaction conditions
    • C12Q2527/125Specific component of sample, medium or buffer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

본 발명은 실리카 처리를 포함하는 표적 RNA 검출 방법, 타겟 RNA의 상보적인 서열을 포함하는 센서 DNA; 및 실리카를 포함하는, RNA 검출용 조성물. 및 실리카 처리를 포함하는 단일가닥 DNA 제거방법에 관한 것이다.
특히, 본 발명은 실리카 처리를 통해 단일가닥 DNA에 의한 비특이적 반응을 제거하여 높은 민감도 및 정확도로 타겟 RNA검출을 가능하게 함으로써 감염증, 암 등 여러 질환의 진단 용도로도 널리 활용될 수 있다.
The present invention relates to a method for detecting a target RNA including silica treatment, a sensor DNA comprising a complementary sequence of the target RNA; And a composition for detecting RNA comprising silica. And it relates to a single-stranded DNA removal method comprising silica treatment.
In particular, the present invention can be widely used for diagnosis of various diseases such as infections and cancers by removing non-specific reactions by single-stranded DNA through silica treatment to enable detection of target RNA with high sensitivity and accuracy.

Description

실리카 처리를 포함하는 표적 RNA 검출 방법{A METHOD OF DETECTING TARGET RNA COMPRISING SILICA TREATMENT}Target RNA detection method including silica treatment {A METHOD OF DETECTING TARGET RNA COMPRISING SILICA TREATMENT}

본 발명은 실리카 처리를 포함하는 표적 RNA 검출 방법, 타겟 RNA의 상보적인 서열을 포함하는 센서 DNA; 및 실리카를 포함하는, RNA 검출용 조성물. 및 실리카 처리를 포함하는 단일가닥 DNA 제거방법에 관한 것이다. The present invention relates to a method for detecting a target RNA including silica treatment, a sensor DNA comprising a complementary sequence of the target RNA; And a composition for detecting RNA comprising silica. And it relates to a single-stranded DNA removal method comprising silica treatment.

삶의 질이 향상되면서 질병의 조기 진단에 대한 관심이 커지고 있으며, 분자진단 기술은 질병을 유발하는 병원체의 유전정보(DNA/RNA)를 직접적으로 검출하기 때문에, 기존의 항원/항체 반응을 기반으로 하여 질병의 간접 인자(indirect factor)를 검출하는 면역진단 기술의 단점을 해결할 수 있는 기술로서 많은 관심을 받고 있다. As the quality of life improves, interest in early diagnosis of disease is growing, and since molecular diagnosis technology directly detects the genetic information (DNA/RNA) of disease-causing pathogens, based on existing antigen/antibody reactions, Therefore, it is attracting much attention as a technology that can solve the disadvantages of immunodiagnostic technology that detects indirect factors of disease.

또한, 최근 코로나바이러스감염증-19(COVID-19)이 크게 유행하면서 전 세계적으로 많은 사망자가 발생하고 WHO에서는 팬데믹 선언까지 하였다. 이러한 RNA 바이러스에 의한 질병의 경우, 높은 돌연변이 발생률에 의해 더욱 큰 피해가 발생되며 감염 여부에 대한 조기 진단이 더욱 요구되고 있다.In addition, the recent coronavirus infection-19 (COVID-19) has been greatly prevalent, resulting in many deaths worldwide, and the WHO has even declared a pandemic. In the case of diseases caused by RNA viruses, greater damage is caused by a high mutation rate, and early diagnosis of infection is further required.

한편, miRNA 등 스몰(small) RNA는 생체 내 존재하는 단백질-비 암호화 RNA로, 특정 유전자의 전사 후 과정에 작용하여 해당 유전자의 발현을 조절할 수 있다. 특히, 세포주기, 분화, 발달, 대사, 발암, 노화와 같은 생물학적 기능을 조절하여 생체의 항상성 유지를 매개하는 중요한 유전적 요소로 인지되며, 특히 이의 비정상적인 네트워크 형성은 세포 생리학적인 측면에서 치명적인 결함을 나타낼 수 있다.On the other hand, small RNAs such as miRNAs are protein-noncoding RNAs that exist in vivo and can regulate the expression of a specific gene by acting on a post-transcriptional process. In particular, it is recognized as an important genetic factor mediating the maintenance of homeostasis in the body by regulating biological functions such as cell cycle, differentiation, development, metabolism, carcinogenesis, and aging. In particular, its abnormal network formation causes fatal defects in terms of cell physiology. can indicate

또한, miRNA 등 스몰 RNA의 혈중 내 발현 양상은 암의 초기 단계에서 민감하게 반응하므로 암의 조기, 예측 발견에 있어서 강한 이점을 나타낸다. 또한 단순한 채혈만으로 다양한 암을 검사할 수 있기에 환자로부터 몸에 가해지는 부담이 감소될 수 있다. 나아가, 상기 감염, 암 외에도 알츠하이머, 파킨슨 병 등 여러 난치성 질환의 진단에 있어서 비특이적 검출 반응을 제거하고RNA를 높은 민감도로 신속하게 검출함으로써 조기 진단이 이루어 질 수 있도록 하는 기술 개발에 대한 요구가 증가되고 있다.In addition, since the expression pattern of small RNAs such as miRNAs in blood responds sensitively in the early stages of cancer, it shows a strong advantage in the early and predictive detection of cancer. In addition, since various cancers can be tested with only simple blood collection, the burden on the body from the patient can be reduced. Furthermore, in the diagnosis of various incurable diseases such as Alzheimer's disease and Parkinson's disease, in addition to the infection and cancer, there is an increasing demand for technology development that enables early diagnosis by eliminating non-specific detection reactions and rapidly detecting RNA with high sensitivity. there is.

한국공개특허 제 10-2007-0018501호 (2007.02.14.)Korean Patent Publication No. 10-2007-0018501 (2007.02.14.)

본 발명의 목적은 실리카를 처리하는 단계를 포함하는, RNA 검출 방법을 제공하는 것이다.An object of the present invention is to provide a method for detecting RNA, comprising the step of treating silica.

본 발명의 다른 목적은 타겟 RNA의 상보적인 서열을 포함하는 센서 DNA; 및 실리카를 포함하는, RNA 검출용 조성물을 제공하는 것이다.Another object of the present invention is a sensor DNA comprising a complementary sequence of the target RNA; And to provide a composition for detecting RNA, including silica.

본 발명의 또 다른 목적은 실리카를 처리하는 단계를 포함하는, 단일가닥 DNA(single strand DNA, ssDNA) 제거 방법을 제공하는 것이다.Another object of the present invention is to provide a single-stranded DNA (ssDNA) removal method comprising the step of treating silica.

상기와 같은 목적을 달성하기 위한 본 발명의 일 측면은, a) 검출 대상이 되는 타겟 RNA의 상보적인 서열을 포함하는 센서DNA를 타겟 RNA와 혼성화하는 단계; b) 상기 센서 DNA의 모듈 영역을 주형으로 하고, 상기 타겟 RNA를 프라이머로 하여 중합효소로 중합하는 단계; 및 c) 실리카를 처리하여 타겟 RNA와 혼성화되지 않은 센서 DNA를 제거하는 단계를 포함하는, RNA 검출 방법에 관한 것이다.One aspect of the present invention for achieving the above object is, a) hybridizing a sensor DNA comprising a complementary sequence of a target RNA to be detected with a target RNA; b) polymerizing with a polymerase using the module region of the sensor DNA as a template and the target RNA as a primer; and c) treating the silica to remove sensor DNA that has not hybridized with the target RNA.

구체적으로, 상기 b) 단계의 중합 단계를 통해 형성된 중합된 가닥을 c) 단계 이후PCR 반응을 통해 증폭하는 단계를 더욱 포함할 수 있다.Specifically, the step of amplifying the polymerized strand formed through the polymerization of step b) through a PCR reaction after step c) may be further included.

또한, 구체적으로 상기 타겟 RNA는 스몰(small) RNA 일 수 있다. 상기 스몰 RNA는 miRNA, siRNA 외에도 약 50개 이하의 뉴클레오티드로 이루어진 RNA를 통칭하는 것일 수 있다.In addition, specifically, the target RNA may be small RNA. The small RNA may collectively refer to RNA consisting of about 50 or less nucleotides in addition to miRNA and siRNA.

본 발명에서, 실리카는 규소의 산화물인 이산화규소(SiO2)로서 실리카의 제형은 멤브레인(membrane), 나노입자, 분말 등으로서 필요에 따라 제한없이 적용될 수 있다.In the present invention, silica is silicon dioxide (SiO 2 ), which is an oxide of silicon, and the formulation of silica may be applied without limitation as needed as a membrane, nanoparticle, powder, or the like.

본 발명 일 실시예에서는 종래 DNA 클린업 방식을 적용하는 대신 실리카를 처리한 경우, 단일가닥(single strand, ss) DNA형태인 타겟 RNA에 미결합한 센서 DNA를 효과적으로 제거함으로써 비특이적 검출 반응이 억제됨을 확인하였다.In one embodiment of the present invention, when silica was treated instead of applying the conventional DNA cleanup method, it was confirmed that the non-specific detection reaction was suppressed by effectively removing sensor DNA unbound to target RNA in the form of single-stranded (ss) DNA. .

또한 구체적으로, 상기 실리카는 pH 7.5 내지 pH 8.5의 조건에서 처리되는 것일 수 있다. Also specifically, the silica may be processed under conditions of pH 7.5 to pH 8.5.

본 발명 일 실시예에서는 실리카가 처리된 경우 pH 7.5 내지 pH 8.5 범위에서 dsDNA는 제거되지 않으면서도 타겟 RNA와 결합되지 않은 센서 DNA(ssDNA)가 제거되어 qPCR 결과가 나타나지 않는 것을 확인하였는 바(도 2), 상기 실리카의 처리는 pH 7.5 내지 pH 8.5 범위에서 ssDNA에 대한 특이적인 제거가 이루어지도록 적용될 수 있다.In one embodiment of the present invention, when silica was treated, it was confirmed that dsDNA was not removed in the range of pH 7.5 to pH 8.5, but sensor DNA (ssDNA) not bound to target RNA was removed, so that qPCR results did not appear (FIG. 2). ), the silica treatment may be applied to achieve specific removal of ssDNA in the range of pH 7.5 to pH 8.5.

본 발명의 다른 측면은 타겟 RNA의 상보적인 서열을 포함하는 센서 DNA; 및 실리카를 포함하는, RNA 검출용 조성물에 관한 것이다.Another aspect of the present invention is a sensor DNA comprising a complementary sequence of the target RNA; And it relates to a composition for RNA detection comprising silica.

구체적으로, 상기 센서 DNA는 타겟 RNA를 인지하여 혼성화하고, 상기 실리카는 타겟 RNA와 혼성화되지 않은 센서 DNA를 제거하는 것일 수 있다. 또한, 상기 센서 DNA는 단일 가닥(single strand, ss) DNA 형태인 것일 수 있다.Specifically, the sensor DNA may recognize and hybridize with the target RNA, and the silica may remove sensor DNA that has not hybridized with the target RNA. In addition, the sensor DNA may be in the form of single strand (ss) DNA.

본 발명 일 실시예에서는 타겟 RNA에 대한 상보적인 서열을 포함하는ssDNA 형태인 센서 DNA를 샘플에 혼합하여 타겟 RNA 검출 반응을 진행하였으며, 상기 검출 반응에 있어서 실리카를 처리한 경우 타겟 RNA와 혼성화되지 않은 미반응 센서 DNA가 효과적으로 제거됨으로써 비특이적 PCR 반응이 억제됨을 확인하였다(도 3 내지 도 9). 이에 따라, 타겟 RNA를 검출하기 위한 센서 DNA 및 실리카를 포함하는 RNA 검출용 조성물은 비특이적 반응을 억제하여 정확도를 향상시킨 검출 반응을 통해 타겟 RNA가 정확히 검출되도록 할 수 있다. In one embodiment of the present invention, a target RNA detection reaction was performed by mixing sensor DNA in the form of ssDNA containing a sequence complementary to the target RNA with a sample, and when silica was treated in the detection reaction, the target RNA was not hybridized. It was confirmed that the non-specific PCR reaction was suppressed by effectively removing unreacted sensor DNA (FIGS. 3 to 9). Accordingly, the RNA detection composition including the sensor DNA and silica for detecting the target RNA can accurately detect the target RNA through a detection reaction with improved accuracy by suppressing a non-specific reaction.

나아가, 본 발명 일 실시예에서는 실리카 처리 단계를 포함한 경우 시판되고 있는 키트를 이용한 종래 DNA 클린업 방식을 적용한 경우에 비해 현저히 낮은 Ct값을 보여 민감도가 현저히 향상되었음을 확인하였다(도 8). 또한, 정량적 검출에 있어서도 실리카를 처리한 경우 종래 DNA 클린업 방식을 적용한 경우에 비해 최소 4 배 내지 300 배 이상의 분자 수를 탐지하였는 바(도 9), 이는 타겟 RNA와 결합되지 않고 남아있는 센서 DNA를 효과적으로 제거하여 비특이적 반응을 현저히 감소시킴으로써 정량적으로도 향상된 검출능을 나타낸 것이다.Furthermore, in one embodiment of the present invention, when the silica treatment step was included, it was confirmed that the sensitivity was remarkably improved by showing a significantly lower Ct value than when a conventional DNA cleanup method using a commercially available kit was applied (FIG. 8). In addition, in the case of quantitative detection, when the silica was treated, at least 4 to 300 times more molecules were detected than when the conventional DNA cleanup method was applied (FIG. 9). By effectively removing it and significantly reducing non-specific reactions, it showed quantitatively improved detection ability.

즉, 본 발명의 실리카 처리 단계를 포함하는 RNA 검출 방법은 종래 엔도뉴클레아제 처리 전후의 DNA 클린업 과정을 거치지 않아 검출 시간을 단축하면서도 비특이적 반응을 제거함으로써 검출 민감도를 현저히 향상시킬 수 있다. That is, the RNA detection method including the silica treatment step of the present invention can significantly improve detection sensitivity by removing non-specific reactions while shortening the detection time by not going through a conventional DNA cleanup process before and after endonuclease treatment.

상기 RNA 검출용 조성물은 센서 DNA; 및 실리카 외에도 완충액, PCR 프라이머 등을 더욱 포함할 수 있으며, 추가로 포함되는 구성요소는 필요에 따라 변경하여 적용될 수 있다.The RNA detection composition may include sensor DNA; And in addition to silica, it may further include a buffer, a PCR primer, and the like, and the additionally included components may be changed and applied as needed.

본 발명의 또 다른 일 측면은 실리카를 처리하는 단계를 포함하는, 단일가닥 DNA(single strand DNA, ssDNA) 제거 방법에 관한 것이다. 구체적으로 상기 실리카는 pH 7.5 내지 pH 8.5의 조건에서 처리되는 것일 수 있다.Another aspect of the present invention relates to a single-stranded DNA (ssDNA) removal method comprising the step of treating silica. Specifically, the silica may be processed under conditions of pH 7.5 to pH 8.5.

본 발명 일 실시예에서는 실리카를 처리하는 경우 타겟 RNA와 결합되지 못한 ssDNA 형태의 센서 DNA가 제거됨을 확인하였는 바, 실리카를 처리하여 ssDNA를 제거하는 방법에 적용할 수 있다.In one embodiment of the present invention, it was confirmed that the sensor DNA in the form of ssDNA that was not bound to the target RNA was removed when the silica was treated, so it can be applied to a method of removing ssDNA by treating the silica.

특히, 상기 실리카는 pH 7.5 내지 pH 8.5 조건에서 처리될 경우, dsDNA는 제거하지 않고 ssDNA만을 제거하는 특이적 반응을 나타내었는 바, pH 7.5 내지 pH 8.5 조건에서 dsDNA의 손실없이 ssDNA를 특이적으로 제거할 수 있다.In particular, when the silica was treated at pH 7.5 to pH 8.5, it showed a specific reaction of removing only ssDNA without removing dsDNA. can do.

본 발명의 RNA 검출 방법 및 검출에 사용되는 센서 DNA의 구성은 검출 한계가 아토몰(amol) 수준으로 매우 낮은 바, 종래 RNA 검출 기술에 비해 민감도 및 정확도가 현저히 우수하다. 특히, 실리카를 처리함으로써 비특이적 반응을 억제하면서도 검출 민감도를 현저히 향상시켰으며, 종래의 DNA 클린업 방식을 적용한 검출 방법에 비해 검출 단계가 감소되어 검출에 소요되는 시간을 단축시킬 수 있다.The RNA detection method of the present invention and the configuration of the sensor DNA used for detection have a detection limit as low as an amol level, so the sensitivity and accuracy are remarkably superior to conventional RNA detection techniques. In particular, by treating the silica, the detection sensitivity is remarkably improved while suppressing the non-specific reaction, and the time required for detection can be shortened because the number of detection steps is reduced compared to the detection method using the conventional DNA cleanup method.

본 발명의 효과는 상기한 효과로 한정되는 것은 아니며, 본 발명의 상세한 설명 또는 청구범위에 기재된 발명의 구성으로부터 추론 가능한 모든 효과를 포함하는 것으로 이해되어야 한다.The effects of the present invention are not limited to the above effects, and should be understood to include all effects that can be inferred from the detailed description of the present invention or the configuration of the invention described in the claims.

도 1은 종래 DNA 클린업 방식 적용 및 본 발명의 실리카 처리 단계 적용시의 반응 순서도를 나타낸 것이다. 실리카 처리의 경우 검출에 필요한 단계가 감소되어 소요 시간이 감축된다.
도 2는 pH에 따른 실리카의 ssDNA 센서, dsDNA 제거 효과를 비교한 결과를 나타낸 것이다.
도 3은 전혈에서의 종래 DNA 클린업 방식 및 실리카 처리시의 ssDNA 센서 제거 효과를 비교한 결과를 나타낸 것이다(-RNA: 타겟 RNA와 미결합된 센서 DNA(ssDNA), +RNA: 타겟 RNA와 결합된 센서 DNA(double strand 형성); 3A: hsa-miR486-5p, 3B: hsa-miR210-3p).
도 4는 혈장(plasma)에서의 종래 DNA 클린업 방식 및 실리카 처리시의 ssDNA 센서 제거 효과를 비교한 결과를 나타낸 것이다(-RNA: 타겟 RNA와 미결합된 센서 DNA(ssDNA), +RNA: 타겟 RNA와 결합된 센서 DNA(double strand 형성)).
도 5 내지 도 7은 멀티플렉스 검출시 비특이적 반응 감소 효과를 비교한 결과를 나타낸 것이다(-RNA: 타겟 RNA와 미결합된 센서 DNA(ssDNA), +RNA: 타겟 RNA와 결합된 센서 DNA(double strand 형성); 5A: hsa-miR486-5p, 5B: hsa-miR1290, 6A: hsa-miR132-3p, 6B: hsa-miR146a-5p, 7A: hsa-miR27a-3p, 7B: hsa-miR31-5p).
도 8은 종래 클린업 방식 적용 및 본 발명의 실리카 처리 단계 적용에 따른 검출 민감도를 Ct값을 통해 확인한 결과를 나타낸 것이다.
도 9는 종래 클린업 방식 적용 및 본 발명의 실리카 처리 단계 적용에 따른 검출 민감도를 qPCR standard curve를 이용한 분자 개수 환산을 통해 확인한 결과를 나타낸 것이다.
1 shows a reaction flow chart when a conventional DNA cleanup method is applied and the silica treatment step of the present invention is applied. In the case of silica treatment, the number of steps required for detection is reduced, thus reducing the required time.
Figure 2 shows the results of comparing the ssDNA sensor and dsDNA removal effects of silica according to pH.
Figure 3 shows the results of comparing the ssDNA sensor removal effect in the conventional DNA cleanup method and silica treatment in whole blood (-RNA: sensor DNA (ssDNA) unbound with target RNA, +RNA: bound with target RNA Sensor DNA (double strand formation; 3A: hsa-miR486-5p, 3B: hsa-miR210-3p).
Figure 4 shows the results of comparing the ssDNA sensor removal effect in the conventional DNA cleanup method and silica treatment in plasma (-RNA: sensor DNA (ssDNA) unbound with target RNA, +RNA: target RNA Sensor DNA combined with (double strand formation)).
5 to 7 show the results of comparing the non-specific reaction reduction effect upon multiplex detection (-RNA: sensor DNA (ssDNA) unbound to target RNA, +RNA: sensor DNA bound to target RNA (double strand) Formation);
8 shows the result of confirming the detection sensitivity through the Ct value according to the application of the conventional cleanup method and the application of the silica treatment step of the present invention.
9 shows the result of confirming the detection sensitivity according to the application of the conventional cleanup method and the application of the silica treatment step of the present invention through conversion of the number of molecules using a qPCR standard curve.

이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by examples. However, the following examples are only to illustrate the present invention, and the present invention is not limited by the following examples.

실시예 1. pH에 따른 실리카의 단일가닥 DNA(ssDNA) 특이적 제거 효과 확인Example 1. Confirmation of single-stranded DNA (ssDNA) specific removal effect of silica according to pH

인간 혈액 샘플로부터 XENOPURE RNA PURIFICATION KIT (whole blood) (cat. No. 93667873-WB)을 사용하여 RNA를 정제한 후 100 ng의 전혈 RNA와 타겟 RNA 인 hsa-miR486-5p의 탐지 센서 DNA(ssDNA) 500 amol를 혼합하였다.After RNA was purified from human blood samples using XENOPURE RNA PURIFICATION KIT (whole blood) (cat. No. 93667873-WB), 100 ng of whole blood RNA and target RNA, detection sensor DNA (ssDNA) of hsa-miR486-5p 500 amol were mixed.

상기 센서 DNA는 타겟 RNA와의 상보적인 서열을 포함하는 센싱 영역을 포함하는 단일가닥 DNA(ssDNA)로서, 상기 센싱 영역은 타겟 RNA를 감지하여 타겟 RNA와 혼성화하는 것으로서, '센서 DNA'로 명명하였다. 타겟 RNA와 혼성화되지 않은 센서 DNA는 ssDNA로 남아 검출에 있어 비특이적 반응을 일으킬 수 있는 바, 검출을 위한 PCR 반응 전에 이를 제거하는 단계가 필요하다. 본 발명에서는 실리카를 혼합하여 센서 DNA에 의한 비특이적 반응을 억제시킬 수 있음을 확인하였다.The sensor DNA is a single-stranded DNA (ssDNA) including a sensing region comprising a sequence complementary to a target RNA, and the sensing region detects and hybridizes with the target RNA, and was named 'sensor DNA'. Since the sensor DNA that is not hybridized with the target RNA remains as ssDNA and may cause a non-specific reaction in detection, a step of removing it is required before the PCR reaction for detection. In the present invention, it was confirmed that non-specific reactions caused by sensor DNA can be suppressed by mixing silica.

타겟 RNA와 센서 DNA가 혼성화되도록 한 후, 타겟 RNA를 주형으로 하고, 센서 DNA를 프라이머로 하여, 2 ㎕의 반응용 완충용액(reaction Buffer, 200 mM Tris-HCl, 100 mM (NH4)2SO4, 100 mM KCl, 20 mM MgSO4, 1% Triton X-100, (pH 8.8, 25°C)), 1 ㎕의 10 mM dNTP 및 DNA 중합효소(XenoT-PoL)를 95 ℃에서 1분 간 가열한 후 63 ℃에서 5 분간 인큐베이션(incubation)하였다.After allowing target RNA and sensor DNA to hybridize, target RNA as a template and sensor DNA as a primer, 2 μl of reaction buffer (200 mM Tris-HCl, 100 mM (NH 4 ) 2 SO 4 , 100 mM KCl, 20 mM MgSO 4 , 1% Triton X-100, (pH 8.8, 25 °C)), 1 μl of 10 mM dNTP and DNA polymerase (XenoT-PoL) at 95 °C for 1 min. After heating, incubation was performed at 63° C. for 5 minutes.

이후, 중합된 가닥을 증폭하는 qPCR 수행 전 별도의 DNA 클린업 과정 없이 pH를 달리하여 실리카 처리 여부에 따른 ssDNA 제거능을 확인하였다.Thereafter, before performing qPCR to amplify the polymerized strand, the ssDNA removal ability according to the silica treatment was confirmed by varying the pH without a separate DNA cleanup process.

각각의 샘플에 실리카(Xenohelix, Cat No. 9366-745422) 30 ug을 혼합한 후 5 mM Tris-HCl, 2.5 mM (NH4)2SO4, 2.5 mM KCl, 0.5 mM MgSO4, 0.025% Triton®X-100 조건에서, 각각 pH가 5.5, 7.5, 8.5, 9.5 및 10.5가 되도록 한 후 5 분 동안 25 ℃에서 볼텍싱(vortexing)하여 혼합하였다.After mixing 30 ug of silica (Xenohelix, Cat No. 9366-745422) with each sample, 5 mM Tris-HCl, 2.5 mM (NH 4 ) 2 SO 4 , 2.5 mM KCl, 0.5 mM MgSO 4 , 0.025% Triton® Under the X-100 condition, the pH was set to 5.5, 7.5, 8.5, 9.5 and 10.5, respectively, and then mixed by vortexing at 25 °C for 5 minutes.

이후 상기와 같이 pH를 달리하여 제조한 각 혼합액을 DNA 컬럼(Xenohelix, Cat No. 9366-3622656B) 으로 옮겨 1분간 6,000 rpm으로 원심분리하여 받은 분리액에 증류수를 첨가하여 200 ㎕로 용리(elution)하였다. 이 중, 3 ul 샘플을 hsa-miR486-5p 센서 특이적 프라이머를 이용하여 각각 95 ℃ 3 분 1사이클, 95 ℃ 10초, 64 ℃ 30초 40 사이클 조건으로 qPCR을 수행하였다.Thereafter, each mixture prepared by varying the pH as described above was transferred to a DNA column (Xenohelix, Cat No. 9366-3622656B), centrifuged at 6,000 rpm for 1 minute, distilled water was added to the separated solution, and elution was performed at 200 μl. did Among these, qPCR was performed on 3 ul samples using the hsa-miR486-5p sensor-specific primer under conditions of 95°C for 3 minutes for 1 cycle, 95°C for 10 seconds, and 64°C for 30 seconds for 40 cycles, respectively.

그 결과, 도 2에 나타난 바와 같이 pH 5.5 조건에서는 타겟 RNA 부존재에 따라 남은 센서 DNA(ssDNA) 및 타겟 RNA와 센서 DNA의 결합 및 중합반응에 따라 생성된 dsDNA(double strand DNA)가 모두 실리카 처리에 의해 제거되었다. As a result, as shown in FIG. 2, in the pH 5.5 condition, both sensor DNA (ssDNA) remaining in the absence of target RNA and dsDNA (double strand DNA) generated according to the binding and polymerization reaction of target RNA and sensor DNA are resistant to silica treatment. was removed by

그러나, pH 7.5~8.5 조건에서는 실리카 처리에 의해 타겟 RNA와 결합되지 않은 센서 DNA(ssDNA)는 제거되어 qPCR 결과가 나타나지 않은 반면, 타겟 RNA의 존재에 따라 센서 DNA가 타겟 RNA에 결합하고 중합반응에 따라 생성된 dsDNA는 제거되지 않고 보존된 것을 확인하였다. 반면, pH 9.5 및 10.5 조건에서는 ssDNA의 제거효과가 감소되었다.However, in pH 7.5-8.5 conditions, sensor DNA (ssDNA) that is not bound to target RNA is removed by silica treatment, and qPCR results are not shown. It was confirmed that the dsDNA produced according to this method was not removed and conserved. On the other hand, the removal effect of ssDNA was reduced in pH 9.5 and 10.5 conditions.

상기와 같은 결과로부터 실리카 처리에 의해 ssDNA가 제거될 수 있으며, 특히 pH 7.5~8.5에서는 ssDNA가 dsDNA와 구분되어 특이적으로 제거됨으로써 타겟 RNA와 결합되지 않고 남아있는 ssDNA 형태의 센서 DNA들만 간편하고 빠른 시간에 제거되는 것을 확인하였다. 이는 본 발명에서 타겟 RNA를 검출함에 있어서 종래 중합반응 이후 DNA 클린업 과정을 거친 후 다시 엔도뉴클레아제 처리 후 DNA 클린업 과정을 거친 후에 PCR 반응이 진행된 것과 달리 DNA 클린업 과정 없이 엔도뉴클레아제 처리 후 실리카를 처리하는 것만으로도 노이즈를 일으킬 수 있는 미결합 센서 DNA를 제거할 수 있다는 점에서 클린업 단계 축소에 따른 검출시간 감소, 미결합 센서 DNA를 특이적으로 제거 가능함에 따른 부정확성을 감소시키는 장점이 있음을 확인한 것이다.From the above results, ssDNA can be removed by silica treatment, and in particular, at pH 7.5-8.5, ssDNA is separated from dsDNA and specifically removed, so that only sensor DNA in the form of ssDNA remaining without being combined with target RNA can be conveniently and quickly It was confirmed that it was removed in time. In detecting the target RNA in the present invention, this is different from the case where the PCR reaction proceeded after the DNA cleanup process after the conventional polymerization reaction and then the endonuclease treatment and the DNA cleanup process, unlike the silica after the endonuclease treatment without the DNA cleanup process. In that unbound sensor DNA that can cause noise can be removed just by processing, it has the advantage of reducing detection time due to reduced cleanup steps and reducing inaccuracy by specifically removing unbound sensor DNA. will confirm

실시예 2. 전혈(whole blood)에서의 실리카의 ssDNA 제거 효과 확인Example 2. Confirmation of ssDNA removal effect of silica in whole blood

인간 혈액 샘플로부터 XENOPURE RNA PURIFICATION KIT (whole blood) (cat. No. 93667873-WB)을 사용하여 RNA를 정제하였다. 이후 100 ng의 전혈 RNA와 타겟 RNA 인 hsa-miR486-5p 및 hsa-miR210-3p 각각의 탐지 센서 DNA(ssDNA) 500 amol씩 혼합하고, 2 ㎕의 반응용 완충용액(reaction Buffer, 200 mM Tris-HCl, 100 mM (NH4)2SO4, 100 mM KCl, 20 mM MgSO4, 1% Triton X-100, (pH 8.8 at 25°C)), 1 ㎕의 10 mM dNTP 및 2 unit의 DNA 폴리머라제(XenoT-POL)를 혼합하였다. 혼합액을 95 ℃에서 1분 간 가열한 후 63 ℃에서 5 분간 인큐베이션 하였다. RNA was purified from human blood samples using the XENOPURE RNA PURIFICATION KIT (whole blood) (cat. No. 93667873-WB). Thereafter, 100 ng of whole blood RNA was mixed with 500 amol of target RNA, hsa-miR486-5p and hsa-miR210-3p detection sensor DNA (ssDNA), and 2 μl of reaction buffer (200 mM Tris- HCl, 100 mM (NH 4 ) 2 SO 4 , 100 mM KCl, 20 mM MgSO 4 , 1% Triton X-100, (pH 8.8 at 25°C)), 1 μl of 10 mM dNTP and 2 units of DNA polymer Rase (XenoT-POL) was mixed. The mixture was heated at 95 °C for 1 minute and then incubated at 63 °C for 5 minutes.

상기 혼합액을 엔도뉴클레아제 처리 후 종래의 DNA 클린업을 진행하는 샘플, 엔도뉴클레아제 처리 후 실리카를 처리하는 샘플로 나누어 진행하였다.The mixed solution was divided into a sample subjected to conventional DNA cleanup after endonuclease treatment and a sample treated with silica after endonuclease treatment.

구체적으로, 혼합액을 20 ㎕씩 나눈 후 이후 종래의 DNA 클린업을 진행하는 샘플에는 시판되고 있는 MEGAquick-spin™Total Fragment DNA Purification Kit를 이용하여 클린업하고, 40 ㎕의 증류수로 용리하여, 엔도뉴클레아제 혼합물(40 mM 소듐아세테이트(sodium acetate, pH 4.5 at 25 °C), 300 mM NaCl, 2 mM ZnSO4 및 200 unit 뉴클레아제(nuclease))을 섞어주고 30 °C에서 10 분간 인큐베이션 하였다. 이후 다시 MEGAquick-spin™Total Fragment DNA Purification Kit을 이용하여 클린업하고, 200 ㎕의 증류수로 용리한 후 3 ul 샘플을 hsa-miR486-5p, hsa-miR210-3p 센서 특이적 프라이머를 이용하여 95 ℃ 3 분 1사이클, 95 ℃ 10초, 64 ℃ 30초 45 사이클조건으로 qPCR을 수행하였다.Specifically, after dividing the mixed solution by 20 μl, clean up using a commercially available MEGAquick-spin™Total Fragment DNA Purification Kit for samples undergoing conventional DNA cleanup, and eluted with 40 μl of distilled water, endonuclease The mixture (40 mM sodium acetate, pH 4.5 at 25 °C), 300 mM NaCl, 2 mM ZnSO 4 and 200 units of nuclease) was mixed and incubated at 30 °C for 10 minutes. Thereafter, cleanup was performed again using the MEGAquick-spin™ Total Fragment DNA Purification Kit, and after elution with 200 μl of distilled water, a 3 ul sample was subjected to hsa-miR486-5p and hsa-miR210-3p sensor specific primers at 95 ° C 3 qPCR was performed under 45 cycle conditions of 1 minute cycle, 95 °C 10 seconds, and 64 °C 30 seconds.

이와 달리, 본 발명의 실리카를 처리하는 단계를 포함하는 방법에 있어서는 엔도뉴클레아제 처리 전 별도의 클린업 과정 없이 20 ㎕의 샘플을 엔도뉴클레아제 혼합물 (5 mM Tris-HCl, 2.5 mM (NH4)2SO4, 2.5 mM KCl, 10.5 mM MgSO4, 2 mM ZnSO4, 0.025% Triton®X-100, pH 6.0) 및 20 unit 엔도뉴클레아제(endonuclease))을 섞어주고 60 °C에서 5 분간 인큐베이션 하였다. 이후 실리카 30 ug을 섞어준 후 2.5 mM Tris-HCl, 1.25 mM (NH4)2SO4, 1.25 mM KCl, 5.25 mM MgSO4, 0.0125% Triton®X-100 조건에서 5 분간 25 ℃에서 볼텍싱하였다. 이후 혼합액을 DNA 컬럼으로 옮겨 1 분간 6,000 rpm으로 원심분리하여 받은 분리액에 증류수를 첨가하여 200 ㎕로 용리하였다. 이 중, 3 ul 샘플을 hsa-miR486-5p, hsa-miR210-3p 센서 특이적 프라이머를 이용하여 각각 95 ℃3 분 1사이클, 95 ℃10초, 64 ℃30초 45 사이클 조건으로 qPCR을 수행하였으며, qPCR 수행 전 별도의 클린업 과정은 거치지 않았다.In contrast, in the method comprising the step of treating the silica of the present invention, 20 μl of the sample was subjected to an endonuclease mixture (5 mM Tris-HCl, 2.5 mM (NH 4 ) 2 SO 4 , 2.5 mM KCl, 10.5 mM MgSO 4 , 2 mM ZnSO 4 , 0.025% Triton®X-100, pH 6.0) and 20 units of endonuclease) at 60 °C for 5 minutes. incubated. Then, after mixing with 30 ug of silica, 2.5 mM Tris-HCl, 1.25 mM (NH 4 ) 2 SO 4 , 1.25 mM KCl, 5.25 mM MgSO 4 , and 0.0125% Triton®X-100 were vortexed at 25 ° C for 5 minutes. . Thereafter, the mixed solution was transferred to a DNA column, centrifuged at 6,000 rpm for 1 minute, and distilled water was added to the separated solution to elute with 200 μl. Among these, 3 ul samples were subjected to qPCR using hsa-miR486-5p and hsa-miR210-3p sensor-specific primers under the conditions of 1 cycle of 95 ° C 3 min, 95 ° C 10 sec, and 45 cycles of 64 ° C 30 sec, respectively. , no separate cleanup process was performed before performing qPCR.

그 결과, 도 3에 나타난 바와 같이 종래의 DNA 클린업 과정 보다 실리카 처리시 타겟 RNA와 미결합된 센서 DNA(ssDNA)의 특이적인 제거가 더 많이 이루어져 qPCR 수행시 더 높은 Ct 값이 나타남을 확인하였다(-RNA: 타겟 RNA와 미결합된 센서 DNA(ssDNA), +RNA: 타겟 RNA와 결합된 센서 DNA(double strand 형성); 3A: hsa-miR486-5p, 3B: hsa-miR210-3p). 또한, 센서 DNA를 달리하여 적용하더라도 동일하게 실리카 처리시 비특이적 반응이 더 많이 제거됨을 확인하였다.As a result, as shown in FIG. 3, it was confirmed that more specific removal of target RNA and unbound sensor DNA (ssDNA) was performed during silica treatment than in the conventional DNA cleanup process, resulting in higher Ct values when performing qPCR ( -RNA: sensor DNA (ssDNA) unbound with target RNA, +RNA: sensor DNA bound with target RNA (double strand formation); 3A: hsa-miR486-5p, 3B: hsa-miR210-3p). In addition, it was confirmed that even when different sensor DNAs were applied, more non-specific reactions were removed when treated with silica.

실시예 3. 혈장(plasma)에서의 실리카의 ssDNA 제거 효과 확인Example 3. Confirmation of ssDNA removal effect of silica in plasma

250 ㎕의 인간 혈장 샘플에서 XENOPURE RNA PURIFICATION KIT (Plasma/Serum) (cat. No. 93667873-SP)를 사용하여 RNA를 정제하였다. 상기 정제된 RNA를 40 ㎕ Elution 버퍼에 용리한 후, 13 ㎕ 샘플에 hsa-miR210-3p 센서 DNA를 500 amol 혼합한 후 2 ㎕의 반응용 완충용액(reaction Buffer, 200 mM Tris-HCl, 100 mM (NH4)2SO4, 100 mM KCl, 20 mM MgSO4, 1% Triton X-100, (pH 8.8, 25°C)), 1 ㎕의 10 mM dNTP 및 2 unit DNA 폴리머라제(XenoT-POL)를 넣어준 후 95 ℃에서 1분 간 가열한 후 63 ℃에서 5 분간 인큐베이션 하였다.RNA was purified from 250 μl of human plasma samples using XENOPURE RNA PURIFICATION KIT (Plasma/Serum) (cat. No. 93667873-SP). After the purified RNA was eluted in 40 μl Elution buffer, 500 amol of hsa-miR210-3p sensor DNA was mixed with 13 μl sample, and then 2 μl of reaction buffer (reaction buffer, 200 mM Tris-HCl, 100 mM (NH 4 ) 2 SO 4 , 100 mM KCl, 20 mM MgSO 4 , 1% Triton X-100, (pH 8.8, 25°C)), 1 μl of 10 mM dNTP and 2 unit DNA polymerase (XenoT-POL ) was added, heated at 95 °C for 1 minute, and then incubated at 63 °C for 5 minutes.

상기 혼합액을 엔도뉴클레아제 처리 후 종래의 DNA 클린업을 진행하는 샘플, 엔도뉴클레아제 처리 후 실리카를 처리하는 샘플로 나누어 진행하였으며, 이하 세부 진행 과정은 상기 실시예 2와 같다.The mixed solution was divided into samples subjected to conventional DNA cleanup after treatment with endonuclease and samples treated with silica after treatment with endonuclease, and the following detailed procedures are the same as in Example 2.

그 결과, 도 4에 나타난 바와 같이 혈장 샘플을 이용한 경우에도 실리카를 처리한 경우 타겟 RNA와 미결합된 센서 DNA의 특이적인 제거가 더 많이 이루어져 qPCR 수행시 더 높은 Ct 값이 나타남을 확인하였다. 특히, 센서 DNA가 타겟 RNA에 결합하고 중합 반응에 따라 생성된 dsDNA의 경우, 실리카 처리시 Ct 값이 더 낮게 나타나 검출 대상의 손실이 감소하는 효과까지 나타남을 확인하였다.As a result, as shown in FIG. 4 , it was confirmed that even in the case of using plasma samples, when the silica was treated, more specific removal of target RNA and unbound sensor DNA occurred, resulting in higher Ct values when qPCR was performed. In particular, in the case of dsDNA generated by polymerization after sensor DNA binds to target RNA, it was confirmed that the Ct value was lower when treated with silica, and thus the loss of the target to be detected was reduced.

즉, 실리카 처리 단계를 포함한 본 발명의 검출 방법은 특히 혈장 내 스몰(small) RNA 탐지에 있어 종래의 DNA 클린업 단계를 포함하는 것에 비해 효율적으로 ssDNA인 센서 DNA를 제거하면서도 검출 대상이 되는 타겟 RNA-센서 DNA 결합에 따라 중합된 dsDNA의 손실을 감소시켜 검출의 정확도 및 민감도를 향상시킬 수 있다.That is, the detection method of the present invention including the silica treatment step efficiently removes sensor DNA, which is ssDNA, while detecting target RNA- It is possible to improve the accuracy and sensitivity of detection by reducing the loss of dsDNA polymerized according to sensor DNA binding.

실시예 4. 멀티플렉스 검출시 비특이적 반응 감소 효과 비교Example 4. Comparison of non-specific reaction reduction effect in multiplex detection

종래의 DNA 클린업과 실리카 처리 각각에 대하여 여러 종류의 센서 DNA 및 타겟 RNA를 혼합하여 멀티플렉스 검출시의 비특이적 검출 반응 감소 효과를 비교하였다.For each of the conventional DNA cleanup and silica treatment, the non-specific detection reaction reduction effect in multiplex detection was compared by mixing several types of sensor DNA and target RNA.

구체적으로, 인간 혈액 샘플에서 RNA 정제 후 100 ng의 전혈 RNA와 6 종의 miRNA(hsa-miR486-5p, hsa-miR1290, hsa-miR132-3p, hsa-miR146a-5p, hsa-miR27a-3p 및 hsa-miR31-5p) 검출을 위한 각각의 센서 DNA 6종을 각 500 amol씩 혼합하였다.Specifically, after RNA purification from human blood samples, 100 ng of whole blood RNA and 6 miRNAs (hsa-miR486-5p, hsa-miR1290, hsa-miR132-3p, hsa-miR146a-5p, hsa-miR27a-3p and hsa -miR31-5p) Each of the 6 types of sensor DNA for detection was mixed with 500 amol each.

이후, 2 ㎕의 반응용 완충용액(reaction Buffer, 200 mM Tris-HCl, 100 mM (NH4)2SO4, 100 mM KCl, 20 mM MgSO4, 1% Triton X-100, (pH 8.8, 25°C)), 1 ㎕의 10 mM dNTP 및 2 unit DNA 폴리머라제(XenoT-POL)를 넣어준 후 95 ℃에서 1분 간 가열한 후 63 ℃에서 5 분간 인큐베이션 하였다.Then, 2 μl of reaction buffer (200 mM Tris-HCl, 100 mM (NH 4 ) 2 SO 4 , 100 mM KCl, 20 mM MgSO 4 , 1% Triton X-100, (pH 8.8, 25 °C)), 1 μl of 10 mM dNTP and 2 unit DNA polymerase (XenoT-POL) were added, heated at 95 °C for 1 minute, and then incubated at 63 °C for 5 minutes.

상기 혼합액을 분리하여 엔도뉴클레아제를 처리한 후, 하나의 샘플은 종래 DNA 클린업 방식을 적용하여 진행하고, 다른 하나의 샘플은 실리카 처리 후 각각 qPCR을 진행하였다. 세부 진행 과정은 상기 실시예 2와 같다.After separating the mixture and treating it with endonuclease, one sample was subjected to a conventional DNA cleanup method, and the other sample was subjected to qPCR after silica treatment. The detailed process is the same as in Example 2 above.

그 결과 도 5 내지 도 7에 나타난 바와 같이 멀티플렉스 방식으로 6 종에 대한 타겟 RNA를 동시에 검출하는 경우에도, 실리카를 처리한 경우 RNA와 미결합된 센서 DNA의 제거 효과가 종래 DNA 클린업 방식을 적용한 경우에 비해 현저히 우수함을 확인하였다.As a result, as shown in FIGS. 5 to 7, even when target RNAs for 6 species are simultaneously detected in a multiplex method, the removal effect of RNA and unbound sensor DNA when treated with silica is obtained by applying the conventional DNA cleanup method. It was confirmed that it was significantly better than the case.

구체적으로, hsa-miR486-5p(도 5A), hsa-miR1290(도 5B), hsa-miR146a-5p(도 6B) 및 hsa-miR31-5p(도 7B)에 대해서는 실리카 처리에 의해 타겟 RNA와 결합되지 않은 센서 DNA(ssDNA)가 완전히 제거되어 타겟 RNA와 결합되지 않은 센서 DNA(ssDNA)는 제거되어 qPCR 결과가 나타나지 않은 반면, 타겟 RNA의 존재에 따라 센서 DNA가 타겟 RNA에 결합하고 중합반응에 따라 생성된 dsDNA는 제거되지 않고 보존된 것을 확인하였다. 그러나, 종래의 DNA 클린업 방식을 적용한 경우에는 센서 DNA가 다량 남아있음을 확인하였다.Specifically, hsa-miR486-5p (FIG. 5A), hsa-miR1290 (FIG. 5B), hsa-miR146a-5p (FIG. 6B) and hsa-miR31-5p (FIG. 7B) bind to target RNA by silica treatment. The sensor DNA (ssDNA) that did not bind to the target RNA was completely removed and the sensor DNA (ssDNA) that did not bind to the target RNA was removed and the qPCR result did not appear. On the other hand, the presence of the target RNA allows the sensor DNA to bind to the target RNA and to It was confirmed that the generated dsDNA was not removed and preserved. However, when the conventional DNA cleanup method was applied, it was confirmed that a large amount of sensor DNA remained.

또한, hsa-miR132-3p(도 6A) 및 hsa-miR27a-3p(도 7A)에 대해서도 종래의 DNA 클린업 과정 보다 실리카 처리시 타겟 RNA와 미결합된 센서 DNA(ssDNA)의 특이적인 제거가 더 많이 이루어져 qPCR 수행시 더 높은 Ct 값이 나타남을 확인하였다.In addition, for hsa-miR132-3p (FIG. 6A) and hsa-miR27a-3p (FIG. 7A), the specific removal of target RNA and unbound sensor DNA (ssDNA) was higher during silica treatment than in the conventional DNA cleanup process. It was confirmed that a higher Ct value appeared when qPCR was performed.

나아가, 본 멀티플렉스 검출에 있어서도 실리카 처리시 Ct 값이 더 낮게 나타나 검출 대상이 되는 타겟 RNA-센서 DNA 결합에 따라 중합된 dsDNA의 손실이 종래 DNA 클린업 방식을 적용한 것에 비해 현저히 감소되었으며, 이로부터 멀티플렉스 검출에 있어서도 검출의 정확도 및 민감도를 향상시킬 수 있음을 확인하였다. Furthermore, in this multiplex detection, the Ct value was lower when treated with silica, and the loss of dsDNA polymerized according to the target RNA-sensor DNA binding to be detected was significantly reduced compared to the conventional DNA cleanup method. It was confirmed that the accuracy and sensitivity of detection can also be improved in plex detection.

상기와 같은 결과는 실리카를 처리함으로써 타겟 RNA와 혼성화하지 못하여 비특이적 반응을 일으킬 수 있는 센서 DNA를 효과적으로 제거하여 비특이적 반응에 의한 결과가 검출 결과에 포함되지 않도록 함을 의미한다. 특히, 종래의 엔도뉴클레아제 처리 전후의 DNA 클린업 과정을 거치지 않아 검출 시간을 단축하면서도 비특이적 반응을 최소화함으로써 검출의 정확도를 현저히 향상시킬 수 있음을 나타낸다.The above result means that by treating the silica, the sensor DNA that can cause a non-specific reaction by failing to hybridize with the target RNA is effectively removed so that the result of the non-specific reaction is not included in the detection result. In particular, it shows that the accuracy of detection can be remarkably improved by minimizing non-specific reactions while shortening the detection time without going through a DNA cleanup process before and after the conventional endonuclease treatment.

실시예 5. 실리카 처리에 따른 검출 민감도 향상 효과 확인Example 5. Confirmation of the effect of improving detection sensitivity by silica treatment

인간 혈액 샘플로부터 XENOPURE RNA PURIFICATION KIT (whole blood) (cat. No. 93667873-WB)을 사용하여 RNA를 정제하였다. 각각 100, 50, 25, 12.5 ng의 전혈 RNA 및 500 amol의 hsa-miR92a-3p 및 hsa-miR27a-3p 각 센서 DNA를 혼합한 후 2 ㎕의 반응용 완충용액(reaction Buffer, 200 mM Tris-HCl, 100 mM (NH4)2SO4, 100 mM KCl, 20 mM MgSO4, 1% Triton X-100, (pH 8.8, 25°C)), 1 ㎕의 10 mM dNTP 및 2 unit의 DNA 폴리머라제(XenoT-POL)를 혼합하였다. 혼합액을 95 ℃에서 1분 간 가열한 후 63 ℃에서 5 분간 인큐베이션 하였다. RNA was purified from human blood samples using the XENOPURE RNA PURIFICATION KIT (whole blood) (cat. No. 93667873-WB). After mixing 100, 50, 25, and 12.5 ng of whole blood RNA and 500 amol of hsa-miR92a-3p and hsa-miR27a-3p sensor DNA, respectively, 2 μl of reaction buffer (200 mM Tris-HCl) , 100 mM (NH 4 ) 2 SO 4 , 100 mM KCl, 20 mM MgSO 4 , 1% Triton X-100, (pH 8.8, 25°C)), 1 μl of 10 mM dNTP and 2 units of DNA polymerase (XenoT-POL) was mixed. The mixture was heated at 95 °C for 1 minute and then incubated at 63 °C for 5 minutes.

상기 혼합액을 분리하여 엔도뉴클레아제를 처리한 후, 하나의 샘플은 종래 DNA 클린업 방식을 적용하여 진행하고, 다른 하나의 샘플은 실리카 처리 후 각각 qPCR을 진행하였다. 세부 진행 과정은 상기 실시예 2와 같다.After separating the mixture and treating it with endonuclease, one sample was subjected to a conventional DNA cleanup method, and the other sample was subjected to qPCR after silica treatment. The detailed process is the same as in Example 2 above.

그 결과, 도 8에 나타난 바와 같이, 실리카를 처리한 경우 종래의 DNA 클린업 방식을 적용한 것에 비해 검출능에서 현저히 향상된 민감도를 보여 hsa-miR27a-3p(도 8A) 및 hsa-miR92a-3p(도 8B) 모두에 대해 100, 50, 25, 12.5 ng에서 더 낮은 Ct값이 나타남을 확인하였다.As a result, as shown in FIG. 8, when the silica was treated, hsa-miR27a-3p (FIG. 8A) and hsa-miR92a-3p (FIG. 8B) showed significantly improved sensitivity in detection ability compared to the conventional DNA cleanup method. ), it was confirmed that lower Ct values appeared at 100, 50, 25, and 12.5 ng for all.

또한, 도 9에 나타난 바와 같이, hsa-miR92a-3p 및 hsa-miR27a-3p 분자 개수에 대한 qPCR standard curve를 이용하여 각 샘플에서 ㎕당 hsa-miR92a-3p 및 hsa-miR27a-3p 각각의 분자 개수를 환산한 결과, 실리카를 처리한 샘플은 종래의 DNA 클린업 방식을 적용한 샘플보다 8.89~367.15 배의 hsa-miR27a-3p(도 9A), 4.28~106.14 배의 hsa-miR92a-3p(도 9B)를 탐지할 수 있음을 확인하였다.In addition, as shown in FIG. 9, the number of molecules of hsa-miR92a-3p and hsa-miR27a-3p per μl in each sample using the qPCR standard curve for the number of molecules of hsa-miR92a-3p and hsa-miR27a-3p As a result of converting , the samples treated with silica contained 8.89 to 367.15 times more hsa-miR27a-3p (FIG. 9A) and 4.28 to 106.14 times more hsa-miR92a-3p (FIG. 9B) than samples applied with the conventional DNA cleanup method. It was confirmed that detection was possible.

즉, 본 발명의 실리카 처리 단계를 포함하는 RNA 검출 방법은 종래의DNA 클린업 방식을 적용한 것에 비해 비특이적 반응을 제거함으로써 검출 민감도를 현저히 향상시켜 정량적으로도 향상된 검출능을 나타낼 수 있다.That is, the RNA detection method including the silica treatment step of the present invention significantly improves detection sensitivity by removing non-specific reactions compared to the conventional DNA cleanup method, and thus can exhibit improved detection ability quantitatively.

상기 실시예 1 내지 5의 각 타겟 RNA 검출을 위한 센서 DNA의 서열은 하기 표 1에 정리된 바와 같다.The sequence of the sensor DNA for detecting each target RNA of Examples 1 to 5 is summarized in Table 1 below.

Figure 112021008904042-pat00001
Figure 112021008904042-pat00001

또한, qPCR 수행시 이용된 프라이머 서열은 하기 표 2에 정리된 바와 같다.In addition, the primer sequences used when performing qPCR are as summarized in Table 2 below.

Figure 112021008904042-pat00002
Figure 112021008904042-pat00002

전술한 본 발명의 설명은 예시를 위한 것이며, 본 발명이 속하는 기술분야의 통상의 지식을 가진 자는 본 발명의 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 쉽게 변형이 가능하다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다. 예를 들어, 단일형으로 설명되어 있는 각 구성 요소는 분산되어 실시될 수도 있으며, 마찬가지로 분산된 것으로 설명되어 있는 구성 요소들도 결합된 형태로 실시될 수 있다.The above description of the present invention is for illustrative purposes, and those skilled in the art can understand that it can be easily modified into other specific forms without changing the technical spirit or essential features of the present invention. will be. Therefore, the embodiments described above should be understood as illustrative in all respects and not limiting. For example, each component described as a single type may be implemented in a distributed manner, and similarly, components described as distributed may be implemented in a combined form.

본 발명의 범위는 후술하는 청구범위에 의하여 나타내어지며, 청구범위의 의미 및 범위 그리고 그 균등 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 본 발명의 범위에 포함되는 것으로 해석되어야 한다The scope of the present invention is indicated by the following claims, and all changes or modifications derived from the meaning and scope of the claims and equivalent concepts should be construed as being included in the scope of the present invention.

<110> Xenohelix. Co., Ltd. <120> A METHOD OF DETECTING TARGET RNA COMPRISING SILICA TREATMENT <130> 20PP31103 <160> 24 <170> KoPatentIn 3.0 <210> 1 <211> 109 <212> DNA <213> Artificial Sequence <220> <223> Sensor DNA for detecting hsa-miR486-5p <400> 1 aacaatacca cgaccaccga caactacacg ctacagtcgc atacgagatt taggcgtgac 60 tggagttgct tggctctggt gtattggttc ggggcagctc agtacagga 109 <210> 2 <211> 110 <212> DNA <213> Artificial Sequence <220> <223> Sensor DNA for detecting hsa-miR210-3p <400> 2 aacaatacca cgaccaccga caactacacg ctacagtcgc atacgagata catcggtgac 60 tggagttgct tggctctggt gtattggttc agccgctgtc acacgcacag 110 <210> 3 <211> 107 <212> DNA <213> Artificial Sequence <220> <223> Sensor DNA for detecting hsa-miR1290 <400> 3 aacaatacca cgaccaccga caactacacg ctacagtcgc atacgagatt cattcgtgac 60 tggagttgct tggctctggt gtattggttc cctgatccaa aaatcca 107 <210> 4 <211> 110 <212> DNA <213> Artificial Sequence <220> <223> Sensor DNA for detecting hsa-miR132-3p <400> 4 aacaatacca cgaccaccga caactacacg ctacagtcgc atacgagatg gcaacgtgac 60 tggagttgct tggctctggt gtattggtcg accatggctg tagactgtta 110 <210> 5 <211> 110 <212> DNA <213> Artificial Sequence <220> <223> Sensor DNA for detecting hsa-miR146a-5p <400> 5 aacaatacca cgaccaccga caactacacg ctacagtcgc atacgagatt agcttgtgac 60 tggagttgct tggctctggt gtattggtaa cccatggaat tcagttctca 110 <210> 6 <211> 109 <212> DNA <213> Artificial Sequence <220> <223> Sensor DNA for detecting hsa-miR27a-3p <400> 6 aacaatacca cgaccaccga caactacacg ctacagtcgc atacgagatc actcagtgac 60 tggagttgct tggctctggt gtattggtgc ggaacttagc cactgtgaa 109 <210> 7 <211> 109 <212> DNA <213> Artificial Sequence <220> <223> Sensor DNA for detecting hsa-miR31-5p <400> 7 aacaatacca cgaccaccga caactacacg ctacagtcgc atacgagatt acagcgtgac 60 tggagttgct tggctctggt gtattggtag ctatgccagc atcttgcct 109 <210> 8 <211> 110 <212> DNA <213> Artificial Sequence <220> <223> Sensor DNA for detecting hsa-miR92a-3p <400> 8 aacaatacca cgaccaccga caactacacg ctacagtcgc atacgagata agtcagtgac 60 tggagttgct tggctctggt gtattggtac aggccgggac aagtgcaata 110 <210> 9 <211> 27 <212> DNA <213> Artificial Sequence <220> <223> Forward primer for detecting hsa-miR486-5p <400> 9 cgctacagtc gcatacgaga tttaggc 27 <210> 10 <211> 22 <212> DNA <213> Artificial Sequence <220> <223> Reverse primer for detecting hsa-miR486-5p <400> 10 tcctgtactg agctgccccg ag 22 <210> 11 <211> 25 <212> DNA <213> Artificial Sequence <220> <223> Forward primer for detecting hsa-miR210-3p <400> 11 ctacagtcgc atacgagata catcg 25 <210> 12 <211> 22 <212> DNA <213> Artificial Sequence <220> <223> Reverse primer for detecting hsa-miR210-3p <400> 12 ctgtgcgtgt gacagcggct ga 22 <210> 13 <211> 26 <212> DNA <213> Artificial Sequence <220> <223> Forward primer for detecting hsa-miR1290 <400> 13 gctacagtcg catacgagat tcattc 26 <210> 14 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> Reverse primer for detecting hsa-miR1290 <400> 14 tggatttttg gatcagggaa ccaa 24 <210> 15 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Forward primer for detecting hsa-miR132-3p <400> 15 gcatacgaga tggcaacgtg 20 <210> 16 <211> 22 <212> DNA <213> Artificial Sequence <220> <223> Reverse primer for detecting hsa-miR132-3p <400> 16 taacagtcta cagccatggt cg 22 <210> 17 <211> 23 <212> DNA <213> Artificial Sequence <220> <223> Forward primer for detecting hsa-miR146a-5p <400> 17 cagtcgcata cgagattagc ttg 23 <210> 18 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> Reverse primer for detecting hsa-miR146a-5p <400> 18 tgagaactga attccatggg ttac 24 <210> 19 <211> 22 <212> DNA <213> Artificial Sequence <220> <223> Forward primer for detecting hsa-miR27a-3p <400> 19 gcatacgaga tcactcagtg ac 22 <210> 20 <211> 21 <212> DNA <213> Artificial Sequence <220> <223> Reverse primer for detecting hsa-miR27a-3p <400> 20 ttcacagtgg ctaagttccg c 21 <210> 21 <211> 22 <212> DNA <213> Artificial Sequence <220> <223> Forward primer for detecting hsa-miR31-5p <400> 21 cagtcgcata cgagattaca gc 22 <210> 22 <211> 21 <212> DNA <213> Artificial Sequence <220> <223> Reverse primer for detecting hsa-miR31-5p <400> 22 aggcaagatg ctggcatagc t 21 <210> 23 <211> 22 <212> DNA <213> Artificial Sequence <220> <223> Forward primer for detecting hsa-miR92a-3p <400> 23 tcgcatacga gataagtcag tg 22 <210> 24 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Reverse primer for detecting hsa-miR92a-3p <400> 24 tattgcactt gtcccggcct 20 <110> Xenohelix. Co., Ltd. <120> A METHOD OF DETECTING TARGET RNA COMPRISING SILICA TREATMENT <130> 20PP31103 <160> 24 <170> KoPatentIn 3.0 <210> 1 <211> 109 <212> DNA <213> artificial sequence <220> <223> Sensor DNA for detecting hsa-miR486-5p <400> 1 aacaatacca cgaccaccga caactacacg ctacagtcgc atacgagatt taggcgtgac 60 tggagttgct tggctctggt gtattggttc ggggcagctc agtacagga 109 <210> 2 <211> 110 <212> DNA <213> artificial sequence <220> <223> Sensor DNA for detecting hsa-miR210-3p <400> 2 aacaatacca cgaccaccga caactacacg ctacagtcgc atacgagata catcggtgac 60 tggagttgct tggctctggt gtattggttc agccgctgtc acacgcacag 110 <210> 3 <211> 107 <212> DNA <213> artificial sequence <220> <223> Sensor DNA for detecting hsa-miR1290 <400> 3 aacaatacca cgaccaccga caactacacg ctacagtcgc atacgagatt cattcgtgac 60 tggagttgct tggctctggt gtattggttc cctgatccaa aaatcca 107 <210> 4 <211> 110 <212> DNA <213> artificial sequence <220> <223> Sensor DNA for detecting hsa-miR132-3p <400> 4 aacaatacca cgaccaccga caactacacg ctacagtcgc atacgagatg gcaacgtgac 60 tggagttgct tggctctggt gtattggtcg accatggctg tagactgtta 110 <210> 5 <211> 110 <212> DNA <213> artificial sequence <220> <223> Sensor DNA for detecting hsa-miR146a-5p <400> 5 aacaatacca cgaccaccga caactacacg ctacagtcgc atacgagatt agcttgtgac 60 tggagttgct tggctctggt gtattggtaa cccatggaat tcagttctca 110 <210> 6 <211> 109 <212> DNA <213> artificial sequence <220> <223> Sensor DNA for detecting hsa-miR27a-3p <400> 6 aacaatacca cgaccaccga caactacacg ctacagtcgc atacgagatc actcagtgac 60 tggagttgct tggctctggt gtattggtgc ggaacttagc cactgtgaa 109 <210> 7 <211> 109 <212> DNA <213> artificial sequence <220> <223> Sensor DNA for detecting hsa-miR31-5p <400> 7 aacaatacca cgaccaccga caactacacg ctacagtcgc atacgagatt acagcgtgac 60 tggagttgct tggctctggt gtattggtag ctatgccagc atcttgcct 109 <210> 8 <211> 110 <212> DNA <213> artificial sequence <220> <223> Sensor DNA for detecting hsa-miR92a-3p <400> 8 aacaatacca cgaccaccga caactacacg ctacagtcgc atacgagata agtcagtgac 60 tggagttgct tggctctggt gtattggtac aggccgggac aagtgcaata 110 <210> 9 <211> 27 <212> DNA <213> artificial sequence <220> <223> Forward primer for detecting hsa-miR486-5p <400> 9 cgctacagtc gcatacgaga tttaggc 27 <210> 10 <211> 22 <212> DNA <213> artificial sequence <220> <223> Reverse primer for detecting hsa-miR486-5p <400> 10 tcctgtactg agctgccccg ag 22 <210> 11 <211> 25 <212> DNA <213> artificial sequence <220> <223> Forward primer for detecting hsa-miR210-3p <400> 11 ctacagtcgc atacgagata catcg 25 <210> 12 <211> 22 <212> DNA <213> artificial sequence <220> <223> Reverse primer for detecting hsa-miR210-3p <400> 12 ctgtgcgtgt gacagcggct ga 22 <210> 13 <211> 26 <212> DNA <213> artificial sequence <220> <223> Forward primer for detecting hsa-miR1290 <400> 13 gctacagtcg catacgagat tcattc 26 <210> 14 <211> 24 <212> DNA <213> artificial sequence <220> <223> Reverse primer for detecting hsa-miR1290 <400> 14 tggatttttg gatcagggaa ccaa 24 <210> 15 <211> 20 <212> DNA <213> artificial sequence <220> <223> Forward primer for detecting hsa-miR132-3p <400> 15 gcatacgaga tggcaacgtg 20 <210> 16 <211> 22 <212> DNA <213> artificial sequence <220> <223> Reverse primer for detecting hsa-miR132-3p <400> 16 taacagtcta cagccatggt cg 22 <210> 17 <211> 23 <212> DNA <213> artificial sequence <220> <223> Forward primer for detecting hsa-miR146a-5p <400> 17 cagtcgcata cgagattagc ttg 23 <210> 18 <211> 24 <212> DNA <213> artificial sequence <220> <223> Reverse primer for detecting hsa-miR146a-5p <400> 18 tgagaactga attccatggg ttac 24 <210> 19 <211> 22 <212> DNA <213> artificial sequence <220> <223> Forward primer for detecting hsa-miR27a-3p <400> 19 gcatacgaga tcactcagtg ac 22 <210> 20 <211> 21 <212> DNA <213> artificial sequence <220> <223> Reverse primer for detecting hsa-miR27a-3p <400> 20 ttcacagtgg ctaagttccg c 21 <210> 21 <211> 22 <212> DNA <213> artificial sequence <220> <223> Forward primer for detecting hsa-miR31-5p <400> 21 cagtcgcata cgagattaca gc 22 <210> 22 <211> 21 <212> DNA <213> artificial sequence <220> <223> Reverse primer for detecting hsa-miR31-5p <400> 22 aggcaagatg ctggcatagc t 21 <210> 23 <211> 22 <212> DNA <213> artificial sequence <220> <223> Forward primer for detecting hsa-miR92a-3p <400> 23 tcgcatacga gataagtcag tg 22 <210> 24 <211> 20 <212> DNA <213> artificial sequence <220> <223> Reverse primer for detecting hsa-miR92a-3p <400> 24 tattgcactt gtcccggcct 20

Claims (10)

a) 검출 대상이 되는 타겟 RNA의 상보적인 서열을 포함하는 센서DNA를 타겟 RNA와 혼성화하는 단계;
b) 상기 센서 DNA의 모듈 영역을 주형으로 하고, 상기 타겟 RNA를 프라이머로 하여 중합효소로 중합하는 단계; 및
c) 실리카를 처리하여 타겟 RNA와 혼성화되지 않은 센서 DNA를 제거하는 단계를 포함하는, RNA 검출 방법에 있어서,
상기 실리카는 pH 7.5 내지 pH 8.5의 조건에서 처리되는 것인, RNA 검출 방법.
a) hybridizing a sensor DNA comprising a sequence complementary to a target RNA to be detected with the target RNA;
b) polymerizing with a polymerase using the module region of the sensor DNA as a template and the target RNA as a primer; and
c) an RNA detection method comprising the step of treating silica to remove sensor DNA that has not hybridized with a target RNA,
Wherein the silica is treated under conditions of pH 7.5 to pH 8.5, RNA detection method.
제1항에 있어서,
상기 b) 단계의 중합 단계를 통해 형성된 중합된 가닥을 c) 단계 이후PCR 반응을 통해 증폭하는 단계를 더욱 포함하는, RNA 검출 방법.
According to claim 1,
Further comprising the step of amplifying the polymerized strand formed through the polymerization step of step b) through a PCR reaction after step c), RNA detection method.
제1항에 있어서,
상기 타겟 RNA는 스몰(small) RNA인 것인, RNA 검출 방법.
According to claim 1,
The target RNA is a small (small) RNA, RNA detection method.
제3항에 있어서, 상기 스몰 RNA는 miRNA인 것인, RNA 검출 방법.The RNA detection method according to claim 3, wherein the small RNA is miRNA. 삭제delete 타겟 RNA의 상보적인 서열을 포함하는 센서 DNA; 및 실리카를 포함하는, RNA 검출용 조성물에 있어서,
상기 실리카는 pH 7.5 내지 pH 8.5의 조건에서 처리되는 것인, RNA 검출용 조성물.
sensor DNA comprising a sequence complementary to the target RNA; And in the RNA detection composition comprising silica,
Wherein the silica is treated under conditions of pH 7.5 to pH 8.5, RNA detection composition.
제6항에 있어서,
상기 센서 DNA는 타겟 RNA를 인지하여 혼성화하고,
상기 실리카는 타겟 RNA와 혼성화되지 않은 센서 DNA를 제거하는 것인, RNA 검출용 조성물.
According to claim 6,
The sensor DNA recognizes and hybridizes with the target RNA,
The silica is to remove the sensor DNA that is not hybridized with the target RNA, RNA detection composition.
제6항에 있어서,
상기 센서 DNA는 단일 가닥(single strand, ss) DNA 형태인 것인, RNA 검출용 조성물.
According to claim 6,
Wherein the sensor DNA is in the form of single strand (ss) DNA, RNA detection composition.
실리카를 처리하는 단계를 포함하는, 단일가닥 DNA(single strand DNA, ssDNA) 제거 방법에 있어서,
상기 실리카는 pH 7.5 내지 pH 8.5의 조건에서 처리되는 것인, 단일가닥 DNA 제거 방법.
In the single-stranded DNA (ssDNA) removal method comprising the step of treating silica,
Wherein the silica is treated under conditions of pH 7.5 to pH 8.5, single-stranded DNA removal method.
삭제delete
KR1020210009517A 2021-01-22 2021-01-22 A method of detecting target rna comprising silica treatment KR102493423B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020210009517A KR102493423B1 (en) 2021-01-22 2021-01-22 A method of detecting target rna comprising silica treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020210009517A KR102493423B1 (en) 2021-01-22 2021-01-22 A method of detecting target rna comprising silica treatment

Publications (2)

Publication Number Publication Date
KR20220106525A KR20220106525A (en) 2022-07-29
KR102493423B1 true KR102493423B1 (en) 2023-01-31

Family

ID=82606485

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020210009517A KR102493423B1 (en) 2021-01-22 2021-01-22 A method of detecting target rna comprising silica treatment

Country Status (1)

Country Link
KR (1) KR102493423B1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070197780A1 (en) 2005-08-09 2007-08-23 Park Jong M Method and apparatus for DNA purification
WO2019199579A1 (en) 2018-04-09 2019-10-17 The Board Of Trustees Of The Leland Stanford Junior University Method of in situ gene sequencing

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070018501A (en) 2005-08-10 2007-02-14 요업기술원 Silica-coated Magnetite Having Amino Substituents Capable of Seperating and Purifying DNA in a High Purity and Large Scale and a Process for Preparing the Same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070197780A1 (en) 2005-08-09 2007-08-23 Park Jong M Method and apparatus for DNA purification
WO2019199579A1 (en) 2018-04-09 2019-10-17 The Board Of Trustees Of The Leland Stanford Junior University Method of in situ gene sequencing

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Juan Dong 등, Anal. Chem., 90, p.7107-7111, 2018.*
Jun Wu 등, ACS Omega, 3, p.5605-5614, 2018.*

Also Published As

Publication number Publication date
KR20220106525A (en) 2022-07-29

Similar Documents

Publication Publication Date Title
AU2018202209B2 (en) Assay for the diagnosis of dermatophytosis
EP2563939B1 (en) Rapid genotyping analysis for human papillomavirus and the device thereof
US20090317820A1 (en) Micro-rna profile in human saliva and its use for detection of oral cancer
JP2017507130A5 (en)
EP3476945B1 (en) Mirna detecting method
CN111206114A (en) Primer and kit for fluorescence PCR (polymerase chain reaction) detection of nine dermatophytes
KR20160106040A (en) Compositions and methods for multimodal analysis of cmet nucleic acids
JP2012507293A5 (en)
CA2865163A1 (en) Multimodal pcr target detection
KR102373532B1 (en) A method of detecting target rna comprising graphene treatment
CN101875970A (en) Rapid detection of APC (Adenomatous Polyposis Coli) gene mutation
KR102493423B1 (en) A method of detecting target rna comprising silica treatment
JP2018506997A (en) Health sign
WO2003076614A1 (en) Method of collecting data for deducing sensitivity to periodontal disease
JP6153515B2 (en) Method for detecting HLA-A * 24: 02 and detection kit
US20210207125A1 (en) Method of isolating nucleic acids for long sequencing reads
WO2010103522A1 (en) Method for detection of nucleic acid sequences
CA2735978A1 (en) Method for simultaneous detection of viroids, pstvd and tcdvd
CN111304322B (en) Preparation method of kit for joint detection of esophageal cancer by four novel circRNAs
KR102587121B1 (en) Composition for isolating rna
JP7335871B2 (en) Multiplex detection of short nucleic acids
KR20100012319A (en) Methods for classifying and identifying sepsis-causing microorganisms
EP2821507A1 (en) A method for detecting, identifying and/or quantifying a pathogen in an individual
KR20240003759A (en) A method of detecting target rna comprising blocker nucleic acid
JP2006508671A5 (en)

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant